Monocytic skin nodules in chronic myelomonocytic leukemia: clinical response to decitabine therapy.
Steensma
David P
DP
Friday
Bret B
BB
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D005260:Female; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000378:metabolism / Q000473:pathology*; D009000:Monocytes / Q000187:drug effects / Q000473:pathology*; D012871:Skin Diseases / Q000188:drug therapy / Q000473:pathology*
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine